Lemonade (LMND)
(Delayed Data from NYSE)
$18.61 USD
+0.22 (1.20%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $18.61 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Lemonade (LMND) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$19.00 | $40.00 | $9.00 | 4.45% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for Lemonade comes to $19.00. The forecasts range from a low of $9.00 to a high of $40.00. The average price target represents an increase of 4.45% from the last closing price of $18.19.
Analyst Price Targets (7 )
Broker Rating
Lemonade currently has an average brokerage recommendation (ABR) of 3.17 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 10 brokerage firms. The current ABR compares to an ABR of 3.17 a month ago based on 10 recommendations.
Of the 10 recommendations deriving the current ABR, one is Strong Buy, representing 10% of all recommendations. A month ago, Strong Buy represented 10%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 6 | 6 | 6 | 6 | 6 |
Sell | 2 | 2 | 2 | 2 | 2 |
Strong Sell | 1 | 1 | 1 | 1 | 1 |
ABR | 3.17 | 3.17 | 3.17 | 3.17 | 3.17 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/2/2024 | Piper Sandler | Arvind Ramnani | Hold | Hold |
5/1/2024 | William Blair | Adam Klauber | Hold | Hold |
5/1/2024 | Not Identified | Not Identified | Hold | Hold |
4/15/2024 | JMP Securities | Karol K Chmiel | Strong Buy | Strong Buy |
4/1/2024 | Dowling & Partners | John Collins | Hold | Hold |
4/1/2024 | Cowen & Co. | Andrew S Kligerman | Hold | Hold |
3/4/2024 | Keefe Bruyette & Woods | Thomas Mcjoynt-Griffith | Hold | Hold |
3/1/2024 | Not Identified | Not Identified | Moderate Sell | Moderate Sell |
9/28/2023 | BMO Capital Markets | Michael Zaremski | Strong Sell | Strong Sell |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.17 |
ABR (Last week) | 3.17 |
# of Recs in ABR | 10 |
Average Target Price | $19.00 |
LT Growth Rate | NA |
Industry | Insurance - Multi line |
Industry Rank by ABR | 177 of 252 |
Current Quarter EPS Est: | -0.85 |